DNM1L and atherosclerosis: IA promotes PSMB5 expression and activates Nrf2 signaling pathway, inhibits Drp1 expression and mitochondrial fission, improves endothelial dysfunction, reduces inflammation and oxidative stress, and exerts anti-atherosclerosis effects through MTFP1